Articles published by Bioventus, Inc.
    Bioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025
    
   October 28, 2025
   From Bioventus, Inc.
   Via GlobeNewswire
    Tickers
      BVS
    
   
    Bioventus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
    
   September 03, 2025
   From Bioventus, Inc.
   Via GlobeNewswire
    Tickers
      BVS
    
   From Bioventus, Inc.
   Via GlobeNewswire
    Tickers
      BVS
    
   
    Bioventus Reports Second Quarter Financial Results
    
   August 06, 2025
   From Bioventus, Inc.
   Via GlobeNewswire
    Tickers
      BVS
    
   
    Bioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation Products
    
   July 30, 2025
   From Bioventus, Inc.
   Via GlobeNewswire
    Tickers
      BVS
    
   
    Bioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025
    
   July 29, 2025
   From Bioventus, Inc.
   Via GlobeNewswire
    Tickers
      BVS
    
   
    Bioventus Reports First Quarter Financial Results
    
   May 06, 2025
   From Bioventus, Inc.
   Via GlobeNewswire
    Tickers
      BVS
    
   
    Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025
    
   April 28, 2025
   From Bioventus, Inc.
   Via GlobeNewswire
    Tickers
      BVS
    
    
   From Bioventus, Inc.
   Via GlobeNewswire
    Tickers
      BVS
    
    
   
    Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025
    
   February 28, 2025
   From Bioventus, Inc.
   Via GlobeNewswire
    Tickers
      BVS
    
    
   From Bioventus, Inc.
   Via GlobeNewswire
    Tickers
      BVS
    
    
   
    Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
    
   January 02, 2025
   From Bioventus, Inc.
   Via GlobeNewswire
    Tickers
      BVS
    
    
   
    Bioventus Reports Third Quarter Financial Results
    
   November 05, 2024
   From Bioventus, Inc.
   Via GlobeNewswire
    Tickers
      BVS
    
    
   
    Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024
    
   October 29, 2024
   From Bioventus, Inc.
   Via GlobeNewswire
    Tickers
      BVS
    
    
   
    Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
    
   October 01, 2024
   From Bioventus, Inc.
   Via GlobeNewswire
    Tickers
      BVS
    
    
   From Bioventus, Inc.
   Via GlobeNewswire
    Tickers
      BVS
    
    
   
    Bioventus Reports Second Quarter Financial Results
    
   August 06, 2024
   From Bioventus, Inc.
   Via GlobeNewswire
    Tickers
      BVS
    
    
   
    Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024
    
   July 30, 2024
   From Bioventus, Inc.
   Via GlobeNewswire
    Tickers
      BVS
    
    
   
    Bioventus Reports First Quarter Financial Results
    
   May 07, 2024
   From Bioventus, Inc.
   Via GlobeNewswire
    Tickers
      BVS
    
    
   
    Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024
    
   April 29, 2024
   From Bioventus, Inc.
   Via GlobeNewswire
    Tickers
      BVS
    
    
   From Bioventus, Inc.
   Via GlobeNewswire
    Tickers
      BVS
    
    
   
    Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024
    
   March 04, 2024
   From Bioventus, Inc.
   Via GlobeNewswire
    Tickers
      BVS
    
    
   
    Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility
    
   January 18, 2024
   From Bioventus, Inc.
   Via GlobeNewswire
    Tickers
      BVS
    
    
   
    Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole
    
   January 12, 2024
   From Bioventus, Inc.
   Via GlobeNewswire
    Tickers
      BVS
    
    
   From Bioventus, Inc.
   Via GlobeNewswire
    Tickers
      BVS
    
    
   
    Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis
    
   December 06, 2023
   From Bioventus, Inc.
   Via GlobeNewswire
    Tickers
      BVS
    
    
   
    Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance
    
   November 07, 2023
   From Bioventus, Inc.
   Via GlobeNewswire
    Tickers
      BVS
    
    
   
    Bioventus to Present at the Cantor Global Healthcare Conference
    
   September 19, 2023
   From Bioventus, Inc.
   Via GlobeNewswire
    Tickers
      BVS
    
    
   
    Bioventus to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
    
   September 06, 2023
   From Bioventus, Inc.
   Via GlobeNewswire
    Tickers
      BVS
    
   
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.